1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Neoplasms With Mesothelin Expression: new trials by email Literature Review of Neoplasms With Mesothelin Expression trials Research Report on Neoplasms With Mesothelin Expression
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mesothelin-Targeted Immunotoxin LMB-100 in Combination With Tofacitinib in Persons With Previously Treated Pancreatic Adenocarcinoma, Cholangiocarcinoma and Other Mesothelin Expressing Solid Tumors LMB-100, Tofacitinib, Mesothelin Expression - Neoplasms With Mesothelin Expression, Epithelioid Mesothelioma | Phase 1 | Completed | National Cancer Institute (NCI) | 19 | 2019-08-29 | 2023-08-01 |
Adenocarcinoma (1) · Cholangiocarcinoma (1)
Carcinoma (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1)
LMB-100 (1) · tofacitinib (1)
National Cancer Institute (NCI) (1)
United States (1)